Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/05/28/3089273/11676/en/Veru-Reports-Positive-Safety-Results-from-Phase-2b-QUALITY-Study-Enobosarm-Added-to-Semaglutide-Led-to-Greater-Fat-Loss-Preservation-of-Muscle-and-Fewer-Gastrointestinal-Side-Effec.html

GLOBENEWSWIRE
28 May 2025

https://www.globenewswire.com/news-release/2024/09/11/2944465/11676/en/Veru-to-Present-at-the-2024-Cantor-Global-Healthcare-Conference.html

GLOBENEWSWIRE
11 Sep 2024

https://www.globenewswire.com/news-release/2024/05/15/2882418/11676/en/Veru-Announces-Steven-B-Heymsfield-M-D-as-the-Principal-Investigator-for-its-Enobosarm-Phase-2b-Clinical-Trial-for-High-Quality-Weight-Loss.html

GLOBENEWSWIRE
15 May 2024

https://www.globenewswire.com/news-release/2024/05/08/2877612/11676/en/Veru-Reports-Fiscal-2024-Second-Quarter-Financial-Results-and-Progress-of-its-Enobosarm-High-Quality-Weight-Loss-Clinical-Program.html

GLOBENEWSWIRE
08 May 2024

https://www.globenewswire.com/news-release/2024/04/01/2855433/11676/en/Veru-Announces-Date-of-2024-Annual-Meeting-of-Shareholders.html

GLOBENEWSWIRE
01 Apr 2024

https://www.globenewswire.com//news-release/2024/02/06/2824317/11676/en/Veru-Announces-FDA-Clearance-of-IND-Application-to-Initiate-Phase-2b-Clinical-Trial-with-Enobosarm-to-Treat-Muscle-Loss-Associated-with-Weight-Loss-Drugs.html

GLOBENEWSWIRE
06 Feb 2024